» Articles » PMID: 34072076

Immunological Aspects of Skin Aging in Atopic Dermatitis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jun 2
PMID 34072076
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The cutaneous immune response is important for the regulation of skin aging well as for the development of immune-mediated skin diseases. Aging of the human skin undergoes immunosenescence with immunological alterations and can be affected by environmental stressors and internal factors, thus leading to various epidermal barrier abnormalities. The dysfunctional epidermal barrier, immune dysregulation, and skin dysbiosis in the advanced age, together with the genetic factors, facilitate the late onset of atopic dermatitis (AD) in the elderly, whose cases have recently been on the rise. Controversial to the healthy aged skin, where overproduction of many cytokines is found, the levels of Th2/Th22 related cytokines inversely correlated with age in the skin of older AD patients. As opposed to an endogenously aged skin, the expression of the terminal differentiation markers significantly increases with age in AD. Despite the atenuated barrier disturbances in older AD patients, the aged skin carries an impairment associated with the aging process, which reflects the persistence of AD. The chronicity of AD in older patients might not directly affect skin aging but does not allow spontaneous remission. Thus, adult- and elderly subtypes of AD are considered as a lifelong disease.

Citing Articles

Achievement of Optimal Treatment Targets with Oral Janus Kinase Inhibition in Elderly Patients with Atopic Dermatitis: A Real-world, Multicenter, Retrospective Study.

Dasilva D, Desir N, Encarnacion I, Issa N, Song E, Mollanazar N J Clin Aesthet Dermatol. 2025; 18(2):25-29.

PMID: 40078855 PMC: 11896624.


Upadacitinib Dose Reduction Regimen in Elderly Patients with Atopic Dermatitis, Guided by Treat-to-Target Consensus Recommendations.

Tong Z, Zeng X, Huang F, Wu Z, Chen H, Zhang Y Am J Clin Dermatol. 2025; .

PMID: 39939577 DOI: 10.1007/s40257-025-00923-1.


Influences on Skin and Intrinsic Aging: Biological, Environmental, and Therapeutic Insights.

Hussein R, Dayel S, Abahussein O, Ali El-Sherbiny A J Cosmet Dermatol. 2024; 24(2):e16688.

PMID: 39604792 PMC: 11845971. DOI: 10.1111/jocd.16688.


Exploring mechanisms of skin aging: insights for clinical treatment.

Zhang M, Lin Y, Han Z, Huang X, Zhou S, Wang S Front Immunol. 2024; 15:1421858.

PMID: 39582871 PMC: 11581952. DOI: 10.3389/fimmu.2024.1421858.


Atopic Dermatitis and the Risk of Myocardial Infarction and All-Cause Mortality: A Nationwide Population-Based Cohort Study.

Woo Y, Cho M, Han K, Cho S, Lee J Allergy Asthma Immunol Res. 2023; 15(5):636-646.

PMID: 37827980 PMC: 10570776. DOI: 10.4168/aair.2023.15.5.636.


References
1.
Akdis C, Akdis M . Immunological differences between intrinsic and extrinsic types of atopic dermatitis. Clin Exp Allergy. 2003; 33(12):1618-21. DOI: 10.1111/j.1365-2222.2003.01803.x. View

2.
Furue M, Yamamura K, Kido-Nakahara M, Nakahara T, Fukui Y . Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis. Allergy. 2017; 73(1):29-36. DOI: 10.1111/all.13239. View

3.
Silverwood R, Forbes H, Abuabara K, Ascott A, Schmidt M, Schmidt S . Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. BMJ. 2018; 361:k1786. PMC: 6190010. DOI: 10.1136/bmj.k1786. View

4.
Suarez-Farinas M, Tintle S, Shemer A, Chiricozzi A, Nograles K, Cardinale I . Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol. 2011; 127(4):954-64.e1-4. PMC: 3128983. DOI: 10.1016/j.jaci.2010.12.1124. View

5.
Jang Y, Choi J, Jin M, Choi Y, Ryoo Z, Lee H . House Dust Mite Increases pro-Th2 Cytokines IL-25 and IL-33 via the Activation of TLR1/6 Signaling. J Invest Dermatol. 2017; 137(11):2354-2361. DOI: 10.1016/j.jid.2017.03.042. View